YUCHAO JIN: Open Payments
NPI 1518454396 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,355 in 333 payments from 31 companies in 2025. Trend: 2023 $3,510 · 2024 $4,583 · 2025 $7,355
Food & beverage: $7,347Education: $7
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 52 | $1,247 |
| ABBVIE INC. | 59 | $1,236 |
| UCB, Inc. | 38 | $935 |
| Amgen Inc. | 49 | $917 |
| Novartis Pharmaceuticals Corporation | 27 | $501 |
| Mallinckrodt Hospital Products Inc. | 18 | $494 |
| Lilly USA, LLC | 10 | $317 |
| Aurinia Pharma U.S., Inc. | 10 | $203 |
| AstraZeneca Pharmaceuticals LP | 9 | $199 |
| Radius Health, Inc. | 9 | $157 |
Products named: TREMFYA, Bimzelx, RINVOQ, ACTHAR, COSENTYX, SKYRIZI, ENBREL, LUPKYNIS.
Industry payments across CA — which companies pay providers there.
